Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial
- Nat. Commun., Aug 18 2025, 16 (1) | https://doi.org/10.1038/s41467-025-63031-y